Related Experiment Video
Updated: Feb 16, 2026
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression
Yun-Li Wu1,2, Yi-Bing Zhu1, Rong-Dong Huang1
1Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.
Background/Aims:
Liver fatty acid-binding protein (FABP1) is a key regulator of hepatic lipid metabolism. MicroRNAs (miRNAs) are thought to be involved in nonalcoholic fatty liver disease (NAFLD), and the underlying mechanism is largely unclear. We investigated whether miRNAs influence hepatocyte steatosis by regulating the FABP1 gene.
Methods:
Candidate FABP1-targeting miRNAs were evaluated using luciferase reporter assay. FABP1 expression was measured using western blotting and quantitative reverse transcription-PCR. Intracellular lipid accumulation was measured based on Oil Red O staining and intracellular triglyceride content. Hepatocyte injury was evaluated based on culture supernatant levels of alanine aminotransferase, aspartate aminotransferase, and intracellular adenosine triphosphate, and mitochondrial membrane potential.
Results:
Dicer1 knockdown significantly elevated FABP1 expression. In total, 68 miRNAs potentially targeting FABP1 were selected; of these, miR-3941, miR-4517, and miR-4672 directly targeted the FABP1 3' untranslated region. Mimics of the three miRNAs substantially repressed FABP1 expression at translational level and led to HepG2 cell resistance to steatosis and cell injury induced by free fatty acids mixture, which rescue of FABP1 overexpression reversed.
Conclusion:
Our findings identify a novel mechanism by which miRNAs protect against hepatocyte steatosis and injury by downregulating FABP1 expression.
Insights
MicroRNAs (miRNAs) protect liver cells from fat buildup and injury by reducing fatty acid-binding protein 1 (FABP1). This discovery offers new insights into nonalcoholic fatty liver disease (NAFLD) mechanisms.
Area of Science:
- Molecular Biology
- Hepatology
- Biochemistry
Background:
- Liver fatty acid-binding protein (FABP1) is crucial for hepatic lipid metabolism.
- MicroRNAs (miRNAs) are implicated in nonalcoholic fatty liver disease (NAFLD), but their precise role is unclear.
- Investigating miRNA regulation of FABP1 in hepatocyte steatosis is essential.
Purpose of the Study:
- To determine if miRNAs regulate FABP1 expression.
- To elucidate the mechanism by which miRNAs affect hepatocyte steatosis and injury.
- To identify specific miRNAs targeting FABP1.
Main Methods:
- Luciferase reporter assays to identify FABP1-targeting miRNAs.
- Western blotting and qRT-PCR to measure FABP1 expression.
- Oil Red O staining and triglyceride assays for lipid accumulation.
- Biochemical assays to assess hepatocyte injury.
Main Results:
- Dicer1 knockdown increased FABP1 expression, suggesting miRNA involvement.
- miR-3941, miR-4517, and miR-4672 were identified as direct regulators of FABP1.
- These miRNAs repressed FABP1 translation, conferring resistance to fatty acid-induced steatosis and injury in HepG2 cells.
- FABP1 overexpression reversed the protective effects of these miRNAs.
Conclusions:
- MicroRNAs protect hepatocytes from steatosis and injury by downregulating FABP1.
- This study reveals a novel miRNA-mediated mechanism in liver disease.
- Targeting these miRNAs could offer therapeutic strategies for NAFLD.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs